Hunan Jingfeng Pharmaceutical Co.,Ltd.

Sümbol: 000908.SZ

SHZ

2.07

CNY

Turuhind täna

-11.5941
P/E suhe
-0.1406
PEG suhe
1.82B
MRK Cap
0.00%
DIV tootlus

Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908-SZ) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 690.609 M, mis on 0.491 % gowth. Kogu perioodi keskmine brutokasum on 459.59 M, mis on 2.233 %. Keskmine brutokasumi suhtarv on 0.387 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.500 %, mis on võrdne 1.939 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Hunan Jingfeng Pharmaceutical Co.,Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.181. Käibevara valdkonnas on 000908.SZ aruandlusvaluutas 571.297. Märkimisväärne osa neist varadest, täpsemalt 181.392, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.054%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 50.456, kui neid on, aruandlusvaluutas. See näitab erinevust -54.662% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 82.36 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.314%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 177.928 aruandlusvaluutas. Selle aspekti aastane muutus on -0.419%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 233.178, varude hind on 120.37 ja firmaväärtus 33.03, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 204.36. Kontovõlad ja lühiajalised võlad on vastavalt 138.54 ja 516.45. Koguvõlg on 598.81, netovõlg on 417.42. Muud lühiajalised kohustused moodustavad 402.16, mis lisandub kohustuste kogusummale 1253.65. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
balance-sheet.row.cash-and-short-term-investments	699.02	181.4	172.2	164.2	405.5	512.1	472.1	1201.9	519.7	214.5	33.4	18.6	16.6	47.3	32.8	53.3	93.9	15.4	65.5	154.1	302	266	174.2	210.5	334.4	291.2	7.9	16.4	6.1
balance-sheet.row.short-term-investments	-4.44	0	-7.4	-103.6	-137.8	343.6	-81.5	-30.5	0	0	0	0	0	0	2.4	-67	0.8	0.3	29.7	54.8	165.3	1.6	0	60	60	50	0	0	0
balance-sheet.row.net-receivables	964.55	233.2	301.3	575.9	877.9	1786.3	1828.1	1742.8	1251	866.6	99.9	108.8	162.9	195.6	205.2	248.2	379.6	261.2	591.2	603.2	324.8	183.4	146.4	53.5	11.1	71.8	47.5	43.8	13.1
balance-sheet.row.inventory	420.12	120.4	155.4	232.4	326.3	268.9	276.1	236.2	160.9	128.6	33.2	41.3	38.5	35.5	31	102.6	71.2	95.6	98.8	90.7	77.9	113.3	92.7	59.8	38.7	19.1	18.6	25.4	17.3
balance-sheet.row.other-current-assets	146.37	36.4	48.7	49.4	173.9	23.1	5.2	16.8	1.9	-138.6	-6.1	-10.3	-15.6	-30.9	-36.6	-44.7	-120.1	0	-221.4	-216.8	0	-27.8	-20.5	130.6	107.1	-21.7	-8.6	-11.4	-2.8
balance-sheet.row.total-current-assets	2230.06	571.3	677.5	1021.9	1783.6	2590.4	2581.6	3197.8	1933.6	1071.2	160.5	158.4	202.4	247.6	232.3	359.3	424.5	372.2	534.1	631.2	704.7	534.9	392.8	454.4	491.3	360.5	65.4	74.3	33.6
balance-sheet.row.property-plant-equipment-net	2189.93	566.4	726.1	1013.8	1232	1049.2	785	667.7	483.9	347.4	83.7	104.2	109.2	104.4	122.5	131	115.7	174.6	180.2	146.3	155	189.2	158.4	115.1	81.7	65	38.6	40.9	24.7
balance-sheet.row.goodwill	132.12	33	33	72	432.7	737.4	705.8	705.8	688.3	355.9	208.6	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	913.89	204.4	210.4	244.8	365.2	348.2	248.5	162.4	70.9	29.6	43.8	58.6	58.6	45.5	321.1	356.1	83.3	105.4	92.2	91.8	103.1	109.1	41.4	49.1	43.8	24	11	4.4	3.1
balance-sheet.row.goodwill-and-intangible-assets	1046.01	237.4	243.5	316.8	797.9	1085.6	954.3	868.2	759.2	385.5	43.8	58.6	58.6	45.5	321.1	356.1	83.7	105.4	92.2	91.8	103.1	109.1	41.4	49.1	43.8	24	11	4.4	3.1
balance-sheet.row.long-term-investments	219	50.5	111.3	270.4	456.5	0	421.8	251.1	0	0	0	0	0	0	46.3	121.6	114.6	169.3	3.3	-35.2	-146.4	29.7	0	-34.9	-37.3	-26.6	0	0	0
balance-sheet.row.tax-assets	103.81	27.9	23.6	64.3	57.2	48	17.1	19.2	20.5	13.6	0	0	0	0.8	1	7.2	7.1	0	0	0	0	0	0	61.1	60.3	50	0	0	0
balance-sheet.row.other-non-current-assets	50.81	15	10.4	2.9	22.9	453.9	109	130	245.4	96.1	48.8	48.8	51.3	73.1	61.5	14	68.7	0.9	30.4	55.4	166.6	3.8	28.2	53.1	52.1	0.3	17.2	12	4.8
balance-sheet.row.total-non-current-assets	3609.56	897.2	1114.8	1668.1	2566.4	2636.7	2287.2	1936.3	1509.1	842.6	176.3	211.7	219	223.8	552.5	629.9	389.9	450.2	306	258.4	278.3	331.7	228	243.5	200.6	112.7	66.8	57.2	32.7
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	5839.62	1468.5	1792.3	2690	4350.1	5227.1	4868.8	5134	3442.6	1913.8	336.8	370.1	421.4	471.4	784.8	989.2	814.4	822.5	840.1	889.6	983	866.7	620.9	697.9	691.9	473.2	132.2	131.5	66.3
balance-sheet.row.account-payables	511.16	138.5	123	186.2	187.1	194.8	114.2	111	134.5	86.7	58.2	61.4	46.4	50	45.6	49.9	53.3	54	62.8	110.1	181.9	79.2	46.5	34.6	16.4	11.2	9.6	7.6	5.4
balance-sheet.row.short-term-debt	2036.35	516.5	864.6	1423.1	1306.5	895.3	621.2	809.4	516.5	480	233.6	296.1	327.8	219	226	367	405.4	358.7	377.1	369.6	340.6	225.1	37.6	81.9	125.3	5	1.1	9	4.4
balance-sheet.row.tax-payables	142.75	47	24.8	7.6	8.9	106.7	109.8	152.4	114.1	61.3	-18.4	-20	-21.3	-24.3	-27.8	-35.4	-19.5	-10.3	-16.2	-21.2	-12.5	-5.3	-2.3	8	8.6	7	1.5	0.5	-0.4
balance-sheet.row.long-term-debt-total	329.82	82.4	8.9	37.8	389	874.3	1182.8	1169.9	160.8	56	-74.7	0	0	114.8	144.8	192.1	0	0	0	10	0	10	24.4	42.7	40.2	27.2	19.3	11	10
Deferred Revenue Non Current	92.18	24.8	51	124.2	173.2	61.6	37.2	38.8	39.7	39	29.7	0	0	-114.8	192.1	0	0	0	0	0	0	0	0	-42.7	-40.2	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	18.31	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	822.32	402.2	2.3	2.8	49.2	186.3	53.6	32.6	24.9	10.5	3.7	8.6	3.9	4.7	16.1	12.6	5.7	7.9	11.3	35.6	29.6	19.3	7	6.7	4.9	3	2.7	3.7	2.9
balance-sheet.row.total-non-current-liabilities	674.69	170.3	103.5	193.2	739.9	981.9	1221.4	1229	224.6	121.9	3.9	4	5.4	119.1	352.2	200.3	6.3	0	0	17	6	10	24.4	46.8	45.7	34.2	19.3	11	10
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	39.59	9.8	7.9	45.6	152.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	4992.99	1253.6	1464.6	2051.8	2408.3	2365	2268.9	2521.6	1194.2	919.8	331.5	430.3	420.7	413.5	684.1	650.6	477.4	486.1	510.5	550.1	563.6	344	122.5	197.4	206.5	72.5	45.7	70.7	35.5
balance-sheet.row.preferred-stock	306.29	0	0	135.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1666.76	416.7	416.7	416.7	416.7	416.7	416.7	416.7	336.7	275.4	280	280	280	280	280	280	280	280	280	280	280	280	280	280	140	140	0	0	0
balance-sheet.row.retained-earnings	-3856.4	-949	-820.9	-657.2	413.4	1296.2	1122.8	982.9	739	466.6	-472.4	-475.7	-414.9	-358	-361	-122.5	-89	-91.9	-94.6	-97.6	-21.3	89.8	77.9	75.3	73.7	28.1	3.8	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	1824.35	710.3	710.6	-135.5	757.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	710.64	0	0	760.5	0	770.7	839	992.6	1097.9	239.2	197.3	135.3	135.3	135.3	134.6	134.2	142.8	146.7	142.8	142.6	141.9	141.4	139.6	135.4	240.5	232.5	82.8	0	0
balance-sheet.row.total-stockholders-equity	651.64	177.9	306.4	520	1588	2483.7	2378.5	2392.2	2173.7	981.2	4.9	-60.5	0.3	57.3	53.7	291.7	333.8	334.8	328.2	325	400.5	511.2	497.5	490.7	454.3	400.6	86.5	60.8	30.8
balance-sheet.row.total-liabilities-and-stockholders-equity	5839.62	1468.5	1792.3	2690	4350.1	5227.1	4868.8	5134	3442.6	1913.8	336.8	370.1	421.4	471.4	784.8	989.2	814.4	822.5	840.1	889.6	983	866.7	620.9	697.9	691.9	473.2	132.2	131.5	66.3
balance-sheet.row.minority-interest	194.99	36.9	21.3	118.1	353.8	378.4	221.4	220.2	74.8	12.8	0.4	0.3	0.5	0.6	47	47	3.1	1.6	1.5	14.5	18.8	11.5	0.9	9.8	31.1	0	0	0	0
balance-sheet.row.total-equity	846.63	214.8	327.7	638.2	1941.8	2862.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	5839.62	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	214.55	50.5	103.9	166.8	318.8	343.6	340.3	220.6	235.9	86.4	45.6	45.7	48.6	48.6	48.7	54.6	115.4	169.7	32.9	19.7	18.8	31.3	25.7	25.1	22.7	23.4	16.7	11.2	3.8
balance-sheet.row.total-debt	2366.17	598.8	873.5	1423.1	1695.5	1769.6	1804	1979.2	677.3	536	233.6	296.1	327.8	333.8	370.8	367	405.4	358.7	377.1	379.6	340.6	235.1	62.1	124.6	165.5	32.2	20.5	20	14.4
balance-sheet.row.net-debt	1667.15	417.4	701.3	1258.9	1290	1257.5	1331.9	777.3	157.5	321.5	200.1	277.5	311.2	286.5	340.4	313.7	312.3	343.6	341.2	280.3	203.8	-29.4	-112.2	-25.9	-109	-209.1	12.5	3.6	8.3

Rahavoogude aruanne

Hunan Jingfeng Pharmaceutical Co.,Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.280 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.000 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli 221731090.000. See on -0.187 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 55.41, 118.33, -454.23, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -39.63 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 157.68, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	-128.24	-100.9	-201.6	-1047.7	-921.6	198.5	185.2	388.1	370.2	257.4	3.4	-60.9	-57.1	2.9	-244	-31.9	5.8	2.7	3	-65.3	14.7	14.4	11.9	46.3	56.8	29.3
cash-flows.row.depreciation-and-amortization	12	55.4	107.5	81.5	76.4	92.6	73.4	60.4	41.7	27.5	8.3	8.8	9.1	9.8	19.1	15.7	11.1	11.9	10.7	10.4	12.5	9.9	6.9	5.6	4.4	0
cash-flows.row.deferred-income-tax	0	0	0	-6.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	6.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	92.2	72.5	321.9	158.5	498.9	-53.1	-222.5	-517.7	-384.8	-118.4	-5.9	15.2	20.2	-59.2	43.3	27.7	38.8	13.4	-95.6	-159.4	-19	-13.1	20.1	-70.3	-32.2	0
cash-flows.row.account-receivables	54.92	54.9	254.9	274	449.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	37.28	37.3	69.4	82.4	-58.7	7.9	-39.9	9.8	-9.1	-10.4	6.5	-7.2	-4.2	-4.6	49.9	-32.2	24.4	3.3	-24.1	-16.1	-21.5	-16	-32.9	-21.1	-17.6	0
cash-flows.row.account-payables	0	-54.9	-254.9	-191.9	-449.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	35.2	252.6	-5.9	557.6	-61	-182.7	-527.5	-375.7	-108	-12.4	22.4	24.4	-54.6	-6.6	60	14.4	10.2	-71.5	-143.3	2.5	2.8	53	-49.2	-14.5	0
cash-flows.row.other-non-cash-items	-41.86	96.2	-103.9	536	382.4	112.9	115.5	81.5	65.2	39.4	-9.3	37.3	20.9	31.2	169.7	19.6	-3.4	29.8	22.4	57.8	14.3	6.4	-8.3	-6.6	-15.4	-29.3
cash-flows.row.net-cash-provided-by-operating-activities	-65.89	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-16.67	-13.5	-38.1	-96	-113.6	-171.1	-303.2	-252.8	-223.2	-100.6	-1.7	-5.2	-4.8	-3.9	-11.8	-26.9	-0.6	-0.6	-1.3	-5.5	-15.2	-99.8	-41.5	-45.6	-18.3	-4.1
cash-flows.row.acquisitions-net	-8.8	63.6	253.4	434.2	135.6	-10.1	-317.3	-243.3	-532.7	-321.1	0.7	0	10.1	42.2	12.3	0.1	0.1	1.8	1.3	10.7	2	0	41.5	0.2	0.2	0
cash-flows.row.purchases-of-investments	0	0	0	-250	-322	-120	303.3	-106	0	0	0	-0.8	0	-0.3	-8.8	-14.2	-31.3	-34.8	-6	-37.3	-0.1	-7	-6.9	-122.4	-112	-50.4
cash-flows.row.sales-maturities-of-investments	0.03	53.3	45.4	352.6	231.8	100.6	15.4	102	10.2	0	0	0	0	30.3	14.1	35.8	1.5	3.2	8.2	139	7	5.6	122.1	137.1	58.6	0
cash-flows.row.other-investing-activites	120.56	118.3	12	2	17.4	0.8	-303.2	24	9.3	-15.3	5.2	36.8	0.1	0	-11.8	0.5	1.5	-0.6	-1.3	3.7	-4.2	0.1	-41.5	-24.9	-38.7	0.1
cash-flows.row.net-cash-used-for-investing-activites	95.11	221.7	272.7	442.7	-50.8	-199.7	-605.1	-476.2	-736.4	-437	4.2	30.8	5.3	68.3	-5.9	-4.7	-28.7	-31	0.9	110.5	-10.4	-101.1	73.7	-55.5	-110.2	-54.5
cash-flows.row.debt-repayment	-294.2	-454.2	-585.3	-1214.9	-1252.4	-820.2	-918.8	-803.5	-588.2	-236.3	-131.9	-36.7	-6	-214.9	-61	-188.8	-256.1	-292.2	-205.1	-325	-232.5	-112.6	-136.3	-135.9	-22	-0.6
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-21.47	-39.6	-91.5	-89.2	-86.6	-102.1	-91.4	-132.2	-51.8	-28.7	-53	0	-3.8	-8.1	-16.5	-19.9	-23.4	-29.9	-23.3	-31.1	-16.4	-9.1	-17.2	-8.6	-2.8	-3.2
cash-flows.row.other-financing-activites	166.04	157.7	289.5	889.4	1245	809.8	735.3	2080.1	1589.2	564.9	193.9	5	0	173.9	64.8	142.6	334	274.5	226.1	364.5	186.5	295.4	73.8	101.2	154.6	265.2
cash-flows.row.net-cash-used-provided-by-financing-activities	-156.83	-336.2	-387.3	-414.7	-94	-112.6	-274.9	1144.4	949.3	299.8	9	-31.7	-9.8	-49.1	-12.7	-66.1	54.5	-47.6	-2.3	8.4	-62.4	173.7	-79.7	-43.4	129.7	261.4
cash-flows.row.effect-of-forex-changes-on-cash	0.15	0.2	-0.1	-2	2	1.3	-1.4	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-11.71	9	9.2	-245.7	-106.6	40	-729.8	682.2	305.2	68.8	9.8	-0.6	-11.4	4	-30.5	-39.8	78	-20.7	-60.9	-37.5	-50.3	90.2	24.5	-123.9	33.2	206.9
cash-flows.row.cash-at-end-of-period	695.54	177.9	168.9	159.8	405.5	512.1	472.1	1201.9	519.7	214.5	24.6	14.8	15.4	26.8	22.8	53.3	93.1	15.1	35.8	99.3	214.1	264.4	174.2	150.5	274.4	206.9
cash-flows.row.cash-at-beginning-of-period	707.25	168.9	159.8	405.5	512.1	472.1	1201.9	519.7	214.5	145.7	14.8	15.4	26.8	22.8	53.3	93.1	15.1	35.8	96.8	136.7	264.4	174.2	149.7	274.4	241.3	0
cash-flows.row.operating-cash-flow	-65.89	123.3	123.8	-271.7	36.2	350.9	151.7	12.3	92.4	205.9	-3.4	0.4	-6.9	-15.2	-11.9	31	52.3	57.9	-59.5	-156.4	22.5	17.6	30.5	-25	13.6	0
cash-flows.row.capital-expenditure	-16.67	-13.5	-38.1	-96	-113.6	-171.1	-303.2	-252.8	-223.2	-100.6	-1.7	-5.2	-4.8	-3.9	-11.8	-26.9	-0.6	-0.6	-1.3	-5.5	-15.2	-99.8	-41.5	-45.6	-18.3	-4.1
cash-flows.row.free-cash-flow	-82.56	109.8	85.7	-367.7	-77.5	179.8	-151.6	-240.5	-130.8	105.3	-5.2	-4.8	-11.7	-19.1	-23.6	4.1	51.7	57.3	-60.8	-161.9	7.4	-82.2	-11	-70.7	-4.6	-4.1

Kasumiaruande rida

Hunan Jingfeng Pharmaceutical Co.,Ltd. tulud muutusid võrreldes eelmise perioodiga 0.036%. 000908.SZ brutokasum on teatatud 640.99. Ettevõtte tegevuskulud on 624.14, mille muutus võrreldes eelmise aastaga on -18.030%. Kulud amortisatsioonikulud on 55.41, mis on -0.484% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 624.14, mis näitab -18.030% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 1.674% kasvu võrreldes eelmise aastaga. Tegevustulu on 14.47, mis näitab -1.674% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.500%. Eelmise aasta puhaskasum oli -100.89.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
income-statement-row.row.total-revenue	782.67	840.7	811.2	877.9	1344	2585.7	2583.7	2640.5	2459	1957.4	167.3	145.3	139	217.4	236.4	216.8	187.7	237.6	214.4	258.6	217.1	214.4	171.2	189.3	136	86.4	65.9	68.6	67.5
income-statement-row.row.cost-of-revenue	198.72	199.7	308	318.4	537.1	629.4	552.3	559.3	463.5	289.1	131.6	122	118.7	181.1	242.1	186.5	161.2	170.2	160.9	232.7	204.7	165.6	138	133.6	82.4	48	37	46.3	49.3
income-statement-row.row.gross-profit	583.95	641	503.2	559.5	807	1956.3	2031.3	2081.2	1995.5	1668.3	35.7	23.3	20.3	36.3	-5.7	30.3	26.5	67.4	53.5	25.9	12.4	48.8	33.2	55.7	53.6	38.4	28.9	22.3	18.2
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	30.31	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	60.45	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	393.67	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	109.54	107.3	129.4	142.2	168.5	-11.2	-8.3	30.7	18.1	13.1	2.1	0.9	18.4	27	-7.3	3.1	5.9	2	1.7	1.8	-8	5.7	4.1	6.5	2.3	1	1.6	2.2	0.8
income-statement-row.row.operating-expenses	594.53	624.1	761.4	1074	1362.2	1604.2	1678.8	1570.8	1524	1338.9	42.9	47.9	54.8	46.8	61.5	45.9	30.5	36.6	31.3	62.2	42.4	34.6	34.1	20.3	12.7	10.1	6.1	8.9	8.1
income-statement-row.row.cost-and-expenses	793.25	823.8	1069.4	1392.4	1899.3	2233.6	2231.2	2130.1	1987.5	1628	174.5	169.9	173.6	227.8	303.5	232.4	191.8	206.8	192.2	294.9	247.1	200.2	172.1	153.8	95.1	58.1	43.1	55.2	57.4
income-statement-row.row.interest-income	0.8	1.1	0.6	1.4	6.7	2.2	3.7	2.7	2.6	0.8	0.3	0.1	0.3	0.6	0.6	1.4	1.8	1.2	1.2	2.8	4.7	1.8	2.7	3.9	0	0	0	0	0
income-statement-row.row.interest-expense	43.14	52.4	86.1	106.2	105	84.6	93.5	68.4	49.8	28.5	6.1	20.4	19.8	19.9	30.9	28.9	24.7	29.9	21.8	23.2	16.3	9.3	7.4	8.6	-1.5	2.1	2.4	2.5	3
income-statement-row.row.selling-and-marketing-expenses	393.67	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-12.07	-105	-134	-637.4	-364.5	-108.4	-102.7	-39.8	-37.8	-23.4	10.5	-36.5	-21.8	13.5	-170.8	-16.6	8.8	-28.7	-19.3	-27.8	-21.5	-1.8	8.4	13.6	23.5	4.3	4.2	6	-2.1
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	109.54	107.3	129.4	142.2	168.5	-11.2	-8.3	30.7	18.1	13.1	2.1	0.9	18.4	27	-7.3	3.1	5.9	2	1.7	1.8	-8	5.7	4.1	6.5	2.3	1	1.6	2.2	0.8
income-statement-row.row.total-operating-expenses	-12.07	-105	-134	-637.4	-364.5	-108.4	-102.7	-39.8	-37.8	-23.4	10.5	-36.5	-21.8	13.5	-170.8	-16.6	8.8	-28.7	-19.3	-27.8	-21.5	-1.8	8.4	13.6	23.5	4.3	4.2	6	-2.1
income-statement-row.row.interest-expense	43.14	52.4	86.1	106.2	105	84.6	93.5	68.4	49.8	28.5	6.1	20.4	19.8	19.9	30.9	28.9	24.7	29.9	21.8	23.2	16.3	9.3	7.4	8.6	-1.5	2.1	2.4	2.5	3
income-statement-row.row.depreciation-and-amortization	89.86	55.4	107.5	276.4	138	92.6	73.4	60.4	41.7	27.5	8.3	8.8	9.1	9.8	19.1	15.7	11.1	11.9	10.7	10.4	12.5	9.9	6.9	5.6	4.4	-5	-4.9	-6.1	0.9
income-statement-row.row.ebitda-caps	-6.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-96.26	14.5	-21.5	-514.5	-555.3	254.9	258.1	440.9	415.8	293.6	2.5	-61.9	-55.2	-24	-230.6	-35	-1.1	1.6	2.7	-67.2	-50.9	16.3	12.2	52.8	64	33.3	27.7	19.5	9.2
income-statement-row.row.income-before-tax	-108.33	-90.6	-155.4	-1151.9	-919.8	243.8	249.8	470.6	433.7	306.1	3.3	-61.1	-56.4	3	-238	-32.1	4.8	2.9	3.7	-64.8	-50.2	17.2	11.9	54.1	65.3	33.4	28.1	20.5	9
income-statement-row.row.income-tax-expense	6.1	10.3	46.2	3.4	1.8	45.2	64.6	82.5	63.5	48.7	-0.1	-0.1	0.7	0.1	6.1	-0.2	-1	0.2	0.7	0.5	2.1	3.1	0.9	7.8	8.5	4.1	1.3	1.9	1
income-statement-row.row.net-income	-128.24	-100.9	-201.6	-1155.3	-921.6	186.8	162.1	340	324.1	251	3.4	-60.8	-57	3	-238.4	-33.5	5.7	2.7	3	-65.1	-52.8	14	12.2	46.2	56.8	29.3	26.9	18.7	8